Oncologic Samples

The category Oncologic Samples encompasses diverse human biospecimens of benign, in situ and malignant neoplasm samples like Leukaemia, Lymphoma, Breast, Brain, Eye, Lung, Pancreatic, Prostate, Skin or Uterus Cancer. Procurement takes place from consented donors under strict ethical standards. You can use our filter functions to perform complex searches according to laboratory parameters, disease in clear name or ICD-10 code, patient annotation, such as age, gender, BMI and ethnicity. If you do not find the samples you are looking for, please contact us.

Available filters
Donor Age
-
Donor BMI
-
1,209 Products

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 76
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T1, N0, M0, stage IIA, resectable (not specified)
Medication:
Delix
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
76 Years
BMI:
24.4 kg/m²
Weight:
74 kg
Height:
174 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T1, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Delix (active agent: ramipril)
  • Diovan
  • Kreon
  • Nebilet
  • Ursofalk
  • metformin
Therapy:
  • implant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 126.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.20 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 193.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 114.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 192.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 13.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 17.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 48.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489737
Quant: 14.10 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 11.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290212
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 74
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Cymbalta
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
74 Years
BMI:
22.8 kg/m²
Weight:
59 kg
Height:
161 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Cymbalta
  • Pantozol
  • Ramipril
  • amlodipine
  • antidepressants
  • mirtazapine
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 241.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.00 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 630.80 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 1270.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 99.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 61.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 43.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 43.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489718
Quant: 13.10 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 33.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290237
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 84
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
84 Years
BMI:
26.7 kg/m²
Weight:
65 kg
Height:
156 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Actrapid
  • Carmen
  • Moxonidin
  • Protaphane
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • bisoprolol (Dosages: 2not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin
  • omeprazole (Dosages: 20mg)
  • simvastatine (Dosages: 20mg)
  • valsartan (Dosages: 160mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 154.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490050
Quant: 94.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.95 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 285.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 115.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 35.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.40 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 67.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289825
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 84
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
84 Years
BMI:
26.7 kg/m²
Weight:
65 kg
Height:
156 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Actrapid
  • Carmen
  • Moxonidin
  • Protaphane
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • bisoprolol (Dosages: 2not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin
  • omeprazole (Dosages: 20mg)
  • simvastatine (Dosages: 20mg)
  • valsartan (Dosages: 160mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 154.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490049
Quant: 94.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.95 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 285.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 115.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 35.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.40 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 67.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289824
0.9 mL (€33.75)
Available (€180.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Glucos... - C25.1

Donor:
Gender: Female Age: 75
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Aldactone
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
75 Years
BMI:
24.5 kg/m²
Weight:
62 kg
Height:
159 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Aldactone
  • Digimerck
  • Pantozol
  • Xipamid
  • simvastatine
Therapy:
  • radiotherapy
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 70.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.40 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 42.90 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 29.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 113.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 14.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 12.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 9.80 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 62.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 40.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290246
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 73
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Doxepin/doxepin
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Open
Donor:
Gender:
Female
Age:
73 Years
BMI:
23.9 kg/m²
Weight:
65 kg
Height:
165 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Doxepin/doxepin
  • Targin
  • Torasemid
  • amlodipine
  • antidepressants
  • metamizole
Therapy:
  • material removal
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 132.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 10.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 8.29 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 2600.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 40.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: I100490007
Quant: 15.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490007
Quant: 33.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 6.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289867
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Cancer-An... - C25.1

Donor:
Gender: Female Age: 81
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - T3, M1, stage IV, non-resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
81 Years
BMI:
27.1 kg/m²
Weight:
72 kg
Height:
163 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - T3, M1, stage IV, non-resectable (not specified)
Medication:
  • Actrapid
  • Betahistin
  • L-thyroxine
  • Opipramol
  • Palladon
  • Ramipril
  • acetylsalicylic acid (ASA)
  • insulin
  • metformin
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 126.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.40 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 596.50 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 35.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 155.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 16.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 24.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 70.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.90 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 52.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 16.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290254
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Gamma-... - C25.0

Donor:
Gender: Male Age: 58
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Male
Age:
58 Years
BMI:
29.3 kg/m²
Weight:
95 kg
Height:
180 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Actrapid
  • Pantozol
  • Plavix
  • Ramipril
  • acetylsalicylic acid (ASA)
  • bisoprolol
  • insulin
  • simvastatine
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 84.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.60 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 331.80 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 77.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 273.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 27.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 28.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 64.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489703
Quant: 14.40 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 4.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290256
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c)... - C25.1

Donor:
Gender: Female Age: 73
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - T3, M0, stage III, non-resectable (not specified)
Medication:
Dulcolax
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
73 Years
BMI:
25.1 kg/m²
Weight:
70 kg
Height:
167 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - T3, M0, stage III, non-resectable (not specified)
Medication:
  • Dulcolax (active agent: bisacodyl)
  • L-thyroxine
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 41.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 3.10 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 16.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 12.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 16.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100489726
Quant: 39.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.80 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 124.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290227
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Gamma-Glu... - C25.0

Donor:
Gender: Female Age: 75
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Kreon
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
75 Years
BMI:
20.8 kg/m²
Weight:
52 kg
Height:
158 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Kreon
  • Pantozol
  • lisinopril
  • thiamazole
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 654.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 1.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 1182.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 199.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 52.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 137.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 43.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 11.00 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 11.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 5.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290226
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Female Age: 72
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
72 Years
BMI:
26.6 kg/m²
Weight:
68 kg
Height:
160 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • Digimerck
  • acetylsalicylic acid (ASA) (Dosages: 103not specified)
  • bisoprolol (Dosages: 5mg)
  • ciprofloxacin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 161.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 26.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.70 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 33.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 105.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 79.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 163.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490070
Quant: 20.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.60 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 29.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289798
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Female Age: 72
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Open
Donor:
Gender:
Female
Age:
72 Years
BMI:
26.6 kg/m²
Weight:
68 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • Digimerck
  • acetylsalicylic acid (ASA) (Dosages: 103not specified)
  • bisoprolol (Dosages: 5mg)
  • ciprofloxacin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 161.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 26.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.70 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 33.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 105.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 79.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 163.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490069
Quant: 20.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.60 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 29.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307943
0.9 mL (€33.75)
Available (€180.00)

Human EDTA plasma - Amylase, Amylase, Cancer-Antigen 19-9... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Actrapid
Parameter:
Amylase Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Open
Donor:
Gender:
Female
Age:
59 Years
BMI:
27.5 kg/m²
Weight:
75 kg
Height:
165 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Actrapid
  • Delix (Delix 10 protect, active agent: ramipril)
  • Kreon (Dosages: 40000not specified)
  • L-thyroxine
  • Lyrica (Dosages: 7not specified)
  • Obsidan (Dosages: 25not specified)
  • Protaphane
  • Restex (Restex retard)
  • Valoron
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Amylase
Qual: I100489454
Quant: 4.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100489457
Quant: 4.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 336.10 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: I100489457
Quant: 105.00 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: I100489457
Quant: 29.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 66.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: I100489457
Quant: 11.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290599
0.3 mL (€11.25)
Product not available in this region. (€180.00)

Human EDTA plasma - Glucose, Glycosylated hemoglobin (HbA... - C25.0

Donor:
Gender: Male Age: 79
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T1, N0, M0, stage IIA, resectable (not specified)
Medication:
Lyrica
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Male
Age:
79 Years
BMI:
24.5 kg/m²
Weight:
76 kg
Height:
176 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T1, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Lyrica
  • Pantozol
  • carvedilol
  • metformin
Therapy:
  • radiotherapy
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 64.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 0.60 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 26.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 204.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 12.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 11.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 57.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489709
Quant: 14.40 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 16.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290247
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Amylase, Amylase, Bilirubin - C25.8

Donor:
Gender: Female Age: 80
Diagnosed disease:
C25.8 - Malignant neoplasm of overlapping lesion of pancreas - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Concor
Parameter:
Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose
Open
Donor:
Gender:
Female
Age:
80 Years
BMI:
24.7 kg/m²
Weight:
68 kg
Height:
166 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of overlapping lesion of pancreas [C25.8] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Concor (Dosages: 5not specified)
  • L-thyroxine (Dosages: 100not specified)
  • antidepressants
  • levodopa
  • mirtazapine (Dosages: 15not specified)
  • phenobarbital (Dosages: 15not specified)
  • pravastatin (Dosages: 40not specified)
  • sedative
  • valsartan (Dosages: 80not specified)
  • venlafaxine (Dosages: 75not specified, Venlafaxin retard)
Parameter Result Ref. / Cut-Off Measuring Information
Amylase
Qual: I100489523
Quant: 15.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100489524
Quant: 15.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: I100489524
Quant: 0.15 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 311.80 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 133.00 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290545
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Amylase, Amylase, Bilirubin - C25.0

Donor:
Gender: Male Age: 80
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Arixtra
Parameter:
Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Open
Donor:
Gender:
Male
Age:
80 Years
BMI:
25.9 kg/m²
Weight:
82 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M0, stage IIB, resectable (not specified)
  • Diabetes
  • arterial hypertension
  • pancreas carcinoma - ductal. Adenocarcinoma (not specified)
  • prostatic hyperplasia - benign (not specified)
Medication:
  • Arixtra (Dosages: 2not specified)
  • Pantozol (Dosages: 40not specified)
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • allopurinol
  • amlodipine (Dosages: 10not specified)
  • diltiazem (Dosages: 90not specified)
  • insulin
  • terazosin (Dosages: 2mg)
  • valsartan
Parameter Result Ref. / Cut-Off Measuring Information
Amylase
Qual: I100489466
Quant: 14.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100489468
Quant: 14.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 13.87 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 1897.00 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 167.00 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 151.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 115.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 46.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 9.00 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: I100489468
Quant: 43.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290590
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Gamma-... - C25.1

Donor:
Gender: Female Age: 83
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - M0, stage III, non-resectable (not specified)
Medication:
Carmen
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
83 Years
BMI:
21.3 kg/m²
Weight:
48 kg
Height:
150 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - M0, stage III, non-resectable (not specified)
Medication:
  • Carmen
  • Pantozol
  • Prednisolon
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 95.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.40 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 106.60 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 47.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 111.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 39.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 40.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 48.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489714
Quant: 13.50 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 19.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290242
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Gamma-Glutamyltransferase (gamma-GT, ... - C25.0

Donor:
Gender: Female Age: 72
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Beloc Zok
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
72 Years
BMI:
31.1 kg/m²
Weight:
92 kg
Height:
172 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Beloc Zok
  • Lasix
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 95.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.70 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 0.60 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 67.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 94.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 19.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 26.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.50 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 573.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 568.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290290
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Addel
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Open
Donor:
Gender:
Female
Age:
59 Years
BMI:
24.8 kg/m²
Weight:
70 kg
Height:
168 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Addel
  • Aminoven
  • Cernevit
  • L-thyroxine
  • Meronem
  • Pantozol
  • bisoprolol
  • lercanidipine
  • metoclopramide
  • potassium
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 283.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.20 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 216.10 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 183.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 61.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 49.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.50 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 41.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL (€15.00)
Available (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 67
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Open
Donor:
Gender:
Female
Age:
67 Years
BMI:
24.2 kg/m²
Weight:
65 kg
Height:
164 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • ciprofloxacin
  • hydrochlorothiazide (HCT)
  • lisinopril
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 212.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 18.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 13.22 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 8932.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 113.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 203.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 147.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 119.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 74.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 9.00 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 20.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289819
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 68
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
Medication:
Irbesartan
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Open
Donor:
Gender:
Male
Age:
68 Years
BMI:
20.8 kg/m²
Weight:
60 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
  • Irbesartan
  • Kreon
Therapy:
  • implant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 484.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.00 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 398.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 523.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 96.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 136.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100489736
Quant: 40.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 13.10 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 10.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 8.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290213
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 64
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Glimepirid
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
64 Years
BMI:
23 kg/m²
Weight:
68 kg
Height:
172 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Glimepirid (Dosages: 2mg)
  • L-thyroxine
  • Zopiclon
  • metamizole
  • pramipexole
  • sedative
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 318.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 6.60 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1134.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 840.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 152.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 448.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 260.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 96.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489743
Quant: 11.60 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 3.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290204
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 67
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Open
Donor:
Gender:
Female
Age:
67 Years
BMI:
24.2 kg/m²
Weight:
65 kg
Height:
164 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • ciprofloxacin
  • hydrochlorothiazide (HCT)
  • lisinopril
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 212.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 18.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 13.22 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 8932.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 113.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 203.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 147.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 119.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 74.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 9.00 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 20.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307963
0.9 mL (€33.75)
Available (€180.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Glucos... - C25.1

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
59 Years
BMI:
26 kg/m²
Weight:
69 kg
Height:
163 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Actrapid
  • Euthyrox (Dosages: 100not specified)
  • Kreon
  • Lantus
  • Pantozol (Dosages: 40mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 62.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.40 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 360.40 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 35.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 156.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 33.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 22.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 53.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489685
Quant: 13.40 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 15.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290288
0.4 mL (€15.00)
Product not available in this region. (€180.00)

Human EDTA plasma - Bilirubin, Cancer-Antigen 19-9 (CA 19... - C25.0

Donor:
Gender: Female Age: 75
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Beloc Zok
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase ...
Open
Donor:
Gender:
Female
Age:
75 Years
BMI:
25.3 kg/m²
Weight:
73 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Beloc Zok
  • Losartan
  • Pantozol
  • Simvahexal
  • Xarelto
  • Xipamid
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 78.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.40 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 821.40 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 202.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 130.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 85.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 49.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489701
Quant: 13.60 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 12.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290259
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 75
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Aldactone
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Glucose Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Open
Donor:
Gender:
Male
Age:
75 Years
BMI:
27.1 kg/m²
Weight:
83 kg
Height:
175 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N0, M0, stage IIA, resectable (not specified)
  • Diabetes
  • arterial hypertension
  • pancreas carcinoma - ductal. Adenocarcinoma (not specified)
Medication:
  • Aldactone (Dosages: 25not specified)
  • L-thyroxine (Dosages: 75µg)
  • Novorapid
  • Protaphane
  • Zanipress
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • allopurinol (Dosages: 100mg)
  • carvedilol (Dosages: 12not specified)
  • insulin
  • metformin (Dosages: 1000mg)
  • omeprazole (Dosages: 20mg)
  • simvastatine (Dosages: 20mg)
  • tamsulosin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100489472
Quant: 48.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: I100489472
Quant: 0.33 mg/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 217.00 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 50.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual:
Quant: 90.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290588
0.5 mL (€18.75)
Product not available in this region. (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Androcur
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Open
Donor:
Gender:
Female
Age:
78 Years
BMI:
22.8 kg/m²
Weight:
62 kg
Height:
165 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Androcur (Dosages: 10mg)
  • Gynokadin (Dosages: 7not specified)
  • Kalinor
  • Novaminsulfon
  • Pantozol (Dosages: 40not specified)
  • acetylsalicylic acid (ASA) (Dosages: 101not specified)
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490110
Quant: 89.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.20 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.90 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: I100490110
Quant: 26.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490110
Quant: 30.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289761
0.6 mL (€22.50)
Product not available in this region. (€180.00)

Human EDTA plasma - Amylase, Amylase, Bilirubin - C25.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Apidra
Parameter:
Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Open
Donor:
Gender:
Female
Age:
78 Years
BMI:
30 kg/m²
Weight:
75 kg
Height:
158 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N0, M0, stage IIA, resectable (not specified)
  • Diabetes
  • arterial hypertension
  • pancreas carcinoma - ductal. Adenocarcinoma (not specified)
Medication:
  • Apidra
  • Lantus
  • Lorsatan (Dosages: 50mg)
  • Obsidan (Dosages: 25mg)
  • Siofor (Dosages: 1000not specified)
  • colestyramine
  • digitoxin
  • furosemide (Dosages: 40mg)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Amylase
Qual: I100489480
Quant: 6.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100489484
Quant: 6.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual:
Quant: 13.77 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 217.90 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual:
Quant: 120.00 mg/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 139.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 92.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 46.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 11.80 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: I100489484
Quant: 28.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290585
0.6 mL (€22.50)
Product not available in this region. (€180.00)

Human Urine - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Androcur
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Open
Donor:
Gender:
Female
Age:
78 Years
BMI:
22.8 kg/m²
Weight:
62 kg
Height:
165 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Androcur (Dosages: 10mg)
  • Gynokadin (Dosages: 7not specified)
  • Kalinor
  • Novaminsulfon
  • Pantozol (Dosages: 40not specified)
  • acetylsalicylic acid (ASA) (Dosages: 101not specified)
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490109
Quant: 89.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.20 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.90 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: I100490109
Quant: 26.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490109
Quant: 30.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289376
1.2 mL (€45.00)
Available (€180.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Cancer-An... - C25.0

Donor:
Gender: Female Age: 83
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage III, non-resectable (not specified)
Medication:
Pantozol
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Pancreatic Amylase
Open
Donor:
Gender:
Female
Age:
83 Years
BMI:
21 kg/m²
Weight:
51 kg
Height:
156 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage III, non-resectable (not specified)
Medication:
  • Pantozol
  • lisinopril
Therapy:
  • implant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 245.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 704.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 94.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 14.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 27.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100489746
Quant: 40.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489746
Quant: 13.10 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 9.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH290201
0.4 mL (€15.00)
Product not available in this region. (€180.00)
  • <
  • 1
  • ...
  • ...
  • ...
  • ...
Payment Methods